First Phase 3 trial in eosinophilic esophagitis (EoE) to show a biologic medicine significantly improved structural and histologic measures, while rapidly improving ability to swallow in patients...

Cingulate Therapeutics, a privately-held, clinical-stage, biopharmaceutical company focused on the development of innovative new products for the treatment of Attention Deficit/Hyperactivity...

Elevation Oncology, a clinical stage biopharmaceutical company focused on the development of precision medicines for patients with genomically defined cancers, announced today the presentation of...

Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today announced preliminary results from the Company's mutant KRAS selective inhibitor programs. The...

On October 22, 2020, the opening ceremony of the 25th China (Guzhen) International Lighting Fair (GILF) theming on "Guzhen Lights up the World" was held grandly at Guzhen Convention and Exhibition...

Kennametal (NYSE: KMT) announced today that they will attend the Baird's 2020 Global Industrial Virtual Conference. Details of the conference are as follows: When: Tuesday, November 10, 2020...

Hosted by CNN Chief Medical Correspondent Sanjay Gupta, MD and featuring appearances from world-renowned cellist Yo-Yo Ma, former New York Mayor Michael Bloomberg, Whoopi Goldberg, Martha Stewart,...

Hoteliers and hospitality professionals around the world will be able to tune in on December 14&15 to the virtual INSPIRE2020 event to learn how they can move forward from surviving to thriving....

AMCP Foundation hosted its most recent Best Poster Competition at AMCP Nexus 2020 Virtual on Wednesday, Oct. 21. With the support of CVS Health, student pharmacists, residents, and fellows...

Akebia Therapeutics, Inc. (Nasdaq: AKBA), today announced the presentation of clinical data from its PRO2TECT global Phase 3 program that evaluated the efficacy and safety of vadadustat, Akebia's...